You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 7, Issue 5

May 2014 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access
11 Citations
11,139 Views
26 Pages

14 May 2014

In general, prodrugs are developed to circumvent deficiencies associated with the absorption, distribution, metabolism, excretion or toxicological (ADMET) profile associated with the active drug. In our study, we select bupropion, a drug with broad p...

  • Article
  • Open Access
33 Citations
11,114 Views
13 Pages

14 May 2014

Kryptofix® 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in 18F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before adminis...

  • Article
  • Open Access
61 Citations
7,725 Views
15 Pages

7 May 2014

Biologics such as rituximab are an important component of oncology treatment strategies, although access to such therapies is challenging in countries with limited resources. This study examined access to rituximab and identified potential barriers t...

  • Article
  • Open Access
39 Citations
13,556 Views
13 Pages

Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep

  • Benjamin Baur,
  • Christoph Solbach,
  • Elena Andreolli,
  • Gordon Winter,
  • Hans-Jürgen Machulla and
  • Sven N. Reske

29 April 2014

Since prostate-specific membrane antigen (PSMA) has been identified as a diagnostic target for prostate cancer, many urea-based small PSMA-targeting molecules were developed. First, the clinical application of these Ga-68 labelled compounds in positr...

  • Article
  • Open Access
43 Citations
8,048 Views
15 Pages

Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1

  • Ammar Almaaytah,
  • Shadi Tarazi,
  • Ahmad Abu-Alhaijaa,
  • Yara Altall,
  • Nizar Alshar'i,
  • Khaldon Bodoor and
  • Qosay Al-Balas

25 April 2014

There is great interest in the development of antimicrobial peptides as a potentially novel class of antimicrobial agents. Several structural determinants are responsible for the antimicrobial and cytolytic activity of antimicrobial peptides. In our...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247